Early Access — free while we kick the tires
EdgarHawk

Sivaraman Rukmini

Chief Financial Officer

Officer
4 filings analyzed · 1 company · Latest 2025-09-17

Companies

Company Buys Sells Direction
Nutanix, Inc. NTNX 0 31 Net selling

Activity

September 2025
2025-09-17 Nutanix, Inc. NTNX
medium
Sell
11,391 shares
$892,414
Significance 4/10

CFO Sivaraman Rukmini sold 11,391 shares of NTNX at $78.34 for $892,414.23 on 2025-09-16; stock now at $77.66

CFO Sivaraman Rukmini sold 11,391 shares at $78.34, reducing holdings by 4.3% from 266,028 to 254,637 shares. His prior NTNX trades show a timing pattern of 0 well-timed sells at the 90-day mark, with an average 90-day return of +8.8% after his sales—indicating he consistently missed subsequent gains rather than avoiding declines. Currently the stock trades at $77.66, down 6.5% from its 52-week high of $83.07, though up 11.8% over the past 30 days. Nutanix's fundamentals show a company that is unprofitable on a full-year basis despite 15.4% annual revenue growth, with a notably elevated P/E of 862.89, reflecting limited profitability relative to valuation. This sale does not deviate from the CFO's established pattern at this ticker.

December 2024
2024-12-17 Nutanix, Inc. NTNX
medium
Sell
11,810 shares
$786,871
Significance 5/10

CFO Sivaraman Rukmini sold 11,810 shares at blended $66.63 on 2024-12-17 for $786.9K; holds 190.9K shares post-sale.

Sivaraman Rukmini, CFO of Nutanix, executed 2 separate sales totaling 11,810 shares (11.8K shares) for $786,871.01 ($786.9K) at an average price of $66.63, reducing his holdings by 5.8% to 190.9K shares. The sales occurred at prices ($66.42 and $67.04) above the current price of $66.14, placing them near recent market levels within the 52-week range of $44.90–$73.37. At the NTNX ticker level, Rukmini's prior 5 trades show mixed timing outcomes: only 1 of 5 prior sells at this ticker generated negative 90-day returns (the definition of well-timed for a sell), while the majority saw subsequent price appreciation, suggesting weak predictive timing at this specific holding. Nutanix fundamentals show positive near-term momentum (90-day +15.2%, annual revenue growth +15.4%, latest quarter revenue $591.0M) offset by full-year unprofitability in the most recent fiscal year, reflecting a company in growth mode but not yet solidly profitable.

September 2024
2024-09-17 Nutanix, Inc. NTNX
medium
Sell
24,316 shares
$1,430,939
Significance 5/10

Nutanix CFO Sivaraman sells 24,316 shares for $1.4M at blended $58.85; retains 192,169 shares post-sale.

Sivaraman Rukmini, CFO of Nutanix, executed 2 separate sales on 2024-09-17 totaling 24,316 shares for $1,430,939.47, reducing holdings by 11.2% to 192.2K shares remaining. The company remains unprofitable (net income $-15.6M in the latest quarter) despite solid revenue growth of 17.8% year-over-year, and the stock trades 20.9% below its 52-week high. His prior 5 open-market trades at Nutanix show mixed timing, with 2 of 5 sales well-timed at the 90-day mark, though his cross-ticker record exhibits a 40.00% well-timed rate. This sale represents a substantial reduction in insider holdings and occurs as the stock has recovered 11.7% over the past 30 days, providing context for the execution decision.

June 2024
2024-06-18 Nutanix, Inc. NTNX
medium
Sell
12,566 shares
$668,788
Significance 5/10

CFO Rukmini sells 12,566 shares (8.0% of holdings) for $668,787.87 at Nutanix as stock down 24.0% in 30 days

On 2024-06-18, CFO Sivaraman Rukmini executed 2 separate sales totaling 12,566 shares for $668,787.87 (blended average price $53.22), reducing holdings from 157,468 shares to 144,902 shares. The timing coincides with significant near-term price weakness: the stock has declined 24.0% over the prior 30 days and currently trades at $53.42, down 27.2% from its 52-week high of $73.37. At the same-ticker level, Rukmini's prior 3 NTNX sales (April and September 2023) posted positive 30-day returns (ranging from 4.1% to 10.8%), indicating those sales were followed by stock strength rather than continued weakness. The company's fundamentals show unprofitability (net income of $-15,616,000.00 in the latest quarter despite 17.8% annual revenue growth), which provides context for recent valuation pressure, though the insider's historical cross-ticker selling pattern shows a 0.00% well-timed rate at the 90-day horizon, suggesting no systematic ability to sell ahead of declines.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access